Post-COVID-19 Syndrome: Leveraging the Patient Perspective and Technological Innovations to Enable the Delineation of Effective Treatments

Drugs. 2021 Jul;81(10):1235-1237. doi: 10.1007/s40265-021-01548-4. Epub 2021 Jun 16.

Authors

Matthew T Roe^{1

2}, Bray Patrick-Lake³, Andrew C von Eschenbach^{4

5}

Affiliations

¹ Duke University School of Medicine, 200 Morris Street, Durham, NC, 27710, USA. matthew.roe@duke.edu.
² Verana Health, San Francisco, CA, USA. matthew.roe@duke.edu.
³ Evidation Health, San Mateo, CA, USA.
⁴ Samaritan Health Initiatives, Montgomery, TX, USA.
⁵ Reagan-Udall Foundation, Washington, DC, USA.

No abstract available

Publication types

Letter

MeSH terms

COVID-19 / complications*
COVID-19 / epidemiology
COVID-19 / therapy
Data Collection / instrumentation*
Diffusion of Innovation
Humans
Pandemics
Post-Acute COVID-19 Syndrome
Registries / statistics & numerical data*
SARS-CoV-2
United States / epidemiology